Recent developments highlight Sabra's operational performance and market positioning, including strong Q2 financial results and recognition as a stable dividend payer.

• Sabra Healthcare reported Q2 2026 FFO and revenue results exceeding expectations, indicating operational strength [N1].
• The company is featured among stable dividend stocks paying yields up to 11.5%, reflecting its income stability [N2].
• Sabra's Q1 2026 earnings transcript and Q1 financial results were publicly discussed, providing transparency into operations [N3][N4].
• Analysts have maintained overweight and neutral recommendations on Sabra, indicating continued market interest [N8].
• Sabra's portfolio and tenant credit quality monitoring remain focal points in recent investor communications [N3].

Sabra benefits from stable rental income streams from healthcare tenants and a diversified portfolio that includes triple-net leases and managed senior housing. The company’s active management of tenant credit quality and operational metrics supports portfolio resilience. Recent news indicates operational strength with Q2 FFO and revenue results exceeding expectations and recognition as a stable dividend payer. The company’s access to capital markets and ability to execute real estate transactions provide flexibility for portfolio optimization.

Sabra faces risks from net losses reported in recent quarters and significant expenses including loan loss provisions and operating costs. The healthcare real estate sector is subject to regulatory changes, reimbursement risks, and operational challenges such as labor shortages and increased costs. Tenant bankruptcies or insolvencies could impact rental income. The company’s indebtedness and associated covenants may restrict financial flexibility. Market conditions and macroeconomic factors could affect capital availability and property valuations.

Sabra's moat derives from its specialized focus on healthcare real estate, a sector with high barriers to entry due to regulatory complexity and tenant specialization. Its diversified portfolio across skilled nursing and senior housing properties provides exposure to multiple healthcare sub-sectors. The company's active tenant credit monitoring and management of lease coverage ratios help mitigate credit risk. Additionally, Sabra's scale and established relationships in the healthcare real estate market support its competitive positioning.

• Market and Interest Rate Risks: Increases in market interest rates and inflation may increase borrowing costs and impact property valuations.
• Tenant Credit and Operational Risks: Tenant bankruptcies, insolvencies, or operational difficulties in healthcare facilities could reduce rental income and increase vacancies.
• Regulatory and Reimbursement Risks: Changes in healthcare regulations and reimbursement policies may affect tenants' financial performance and ability to pay rent.
• Liquidity and Capital Access Risks: Restrictions from debt covenants and market conditions may limit Sabra's ability to raise capital or refinance debt on favorable terms.
• Concentration Risks: Concentration in healthcare property sectors, especially skilled nursing and senior housing, increases vulnerability to sector-specific downturns.

• Sabra Health Care REIT, Inc. is a real estate investment trust (REIT) incorporated in 2010 and operating primarily in the healthcare real estate sector [S1].
• The company acquires, finances, and owns real estate properties leased to third-party tenants in the healthcare sector, primarily in the U.S. and Canada [S1].
• Sabra conducts operations through its Delaware limited partnership, Sabra Health Care Limited Partnership, and subsidiaries [S1].
• As of June 30, 2026, Sabra reported cash and cash equivalents of $231.6 million [S2].
• For the quarter ended June 30, 2026, Sabra reported total revenues of approximately $235.9 million, including rental and related revenues and resident fees and services [S2].
• The company reported a net loss of $25.2 million for Q2 2026, with basic and diluted EPS of -$0.10 per share [S2].
• Sabra's total assets as of June 30, 2026, were approximately $5.51 billion, with total liabilities of about $2.76 billion and total equity of approximately $2.75 billion [S2].
• The company’s portfolio includes skilled nursing, senior housing, and other healthcare-related real estate properties [S1].
• Sabra monitors tenant credit quality using lease coverage ratios and parent guarantor fixed charge coverage ratios, evaluating financial and operational trends monthly [S2].
• The company’s revenues are primarily generated from leasing properties to tenants in the healthcare sector, including triple-net leases and managed senior housing portfolios [S1][S2].
• Sabra reported significant expenses in Q2 2026, including depreciation and amortization, interest, operating expenses for triple-net and senior housing managed portfolios, general and administrative expenses, and provisions for loan losses [S2].
• The company recognized net gains on sales of real estate during the period [S2].
• Sabra pays dividends and has a history of common stock issuances and repurchases [S2].
• Recent news highlights include Sabra topping Q2 FFO and revenue estimates and being noted among stable dividend stocks with yields up to 11.5% [N1][N2].
• Sabra’s Q1 2026 earnings transcript and Q1 FFO and revenue results were publicly discussed [N3][N4].
• Analysts and financial outlets have maintained overweight or neutral recommendations on Sabra, reflecting ongoing market interest [N8].